New ultrasound technology can non-invasively measure blood viscosity
November 4, 2025
https://medicalxpress.com/news/2025-11-ultrasound-technology-invasively-blood-viscosity.html
https://medicalxpress.com/news/2025-11-ultrasound-technology-invasively-blood-viscosity.html
Researchers at the Madrid Institute for Advanced Studies in Nanoscience (IMDEA Nanociencia) and the National Center for Biotechnology (CNB-CSIC) have developed an innovative technique to destroy cancer cells by inducing a cascade that spreads throughout the tumor.
MIT engineers have developed a flexible drug-delivery patch that can be placed on the heart after a heart attack to help promote healing and regeneration of cardiac tissue.
Fiber-optic technology revolutionized the telecommunications industry and may soon do the same for brain research.
For the first time, a research team led by the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has mapped the genetic architecture of a crucial part of the human brain known as the corpus callosum—the thick band of nerve fibers that connects the brain’s left and right hemispheres. The findings open new pathways for discoveries about mental illness, neurological disorders and other diseases related to defects in this part of the brain.
Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart problems, like heart attacks and heart failure, the heart muscles become damaged and are difficult to treat and repair.
Having already submitted an application with the FDA, Tulyp is now eyeing a Series A financing round to capture more clinical data and advance R&D.
Bioelectronic devices link microbes and materials to convert chemical signals into electrical outputs for sensing, energy, and synthesis. Unlocking this potential requires systems that can interrogate electroactive cells rapidly and at scale, but traditional bioelectrochemical platforms remain costly, bulky, and low throughput.
The increasing demand for real-time, wireless, and sustainable motion monitoring in applications such as personal health, professional sports, and human-machine interactions calls for wearable devices that are lightweight and battery free.
VANCOUVER, BC, Nov. 3, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial in The Journal of Bone & Joint Surgery (JBJS) which demonstrates the significant benefits of the EmeTerm wristband in reducing postoperative nausea and vomiting (PONV) in patients undergoing total hip or knee arthroplasty (THA/TKA) under spinal anesthesia.